ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

New Drug Approval: Groups Urge FDA To Move Quickly On Herceptin Approval

September 18, 1998

Surgeon General plans new report, database, on tobacco.

January 16, 2004

McCormick President-Elect of AACR; Garber To Start Term As President

March 25, 2011

Cancer Commission Surveying for Pill, Hepatoma Association

October 1, 1976

New NCI Director Varmus “Glad To Be Back,” Says Goal Is To Control Cancer Through Science

July 16, 2010

Senate Finance Reports A Reform Bill On Deadline

July 8, 1994